CatalystWireBeta

Half-year Results

In brief · summary, not quotable

Revenue more than tripled to £25.6m with adjusted EBITDA of £8.7m; strong SpaceX order inflow and healthy order book.

  • Revenue £25.6m (prior £8.5m)
  • Adjusted EBITDA £8.7m (prior £0.2m)
  • Operating profit £6.8m (prior (£0.4m))
  • Profit for the period £6.7m (prior (£0.5m))
  • Basic earnings per share 3.08p (prior (0.24p))
  • Net cash (excl. lease liabilities) £5.1m (prior £5.2m)
Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your FTC notes

Filtronic plc (AIM: FTC), the designer and manufacturer of products and sub-systems for the aerospace, defence, telecoms infrastructure, space and critical communications markets, announces its half year results for the six months ended 30 November 2024 ("H1 2025").

Financial Highlights

H1 2025H1 2024
Revenue£25.6m£8.5m
Adjusted EBITDA ¹£8.7m£0.2m
Operating profit/(loss)£6.8m(£0.4m)
Profit/(loss) for the period£6.7m(£0.5m)
Basic earnings/(loss) per share3.08p(0.24p)
Diluted earnings/(loss) per share3.04p(0.24p)
Cash generated from operating activities£2.1m£1.8m
At 30 Nov 2024At 31 May 2024
Net cash when including right of use property leases£4.3m£4.2m
Net cash when excluding right of use property leases£5.1m£5.2m

¹ Adjusted EBITDA is earnings before interest, taxation, depreciation, amortisation, share-based payments and exceptional items.

Operational Highlights

  • Strong order inflow from SpaceX in the period aligned with the Strategic Partnership agreement.
  • Technology developments progressing well to deliver on our future product roadmap in conjunction with key customers.
  • Excellent progress made with the recruitment drive to scale the engineering team to meet demand and serve the healthy opportunity pipeline. This has resulted in a 16% headcount increase including the recruitment of a design team in Cambridge.
  • Two new production lines installed in the period to increase manufacturing capacity to support revenue growth.
  • Healthy cash position enables continued investment in revenue growth initiatives to deliver the strategic plan.

Post-period Highlights

  • Leadership team further strengthened with three key appointments added.
  • Positive cadence of order intake has continued in H2 resulting in two material upgrades to market expectations in the last two months.

Commenting, Jonathan Neale, Chairman, said: "We are pleased to communicate these strong set of interim results. Robust order intake has resulted in the improved revenue and profit outlook in H2 which we communicated in market upgrades in December 2024 and January 2025. Investing in the business to underpin the orderbook has been timely and effective and we look forward to being able to communicate more about the next financial year as things develop during H2".

Chairman's Statement

I am pleased to present the half year results for FY2025 and update shareholders on the progress we have made in the period. This is not only reflected in the financial results, but also the great strides we have made to develop the organisation and appropriately scale the business.

Engineering recruitment has been more successful, with a significant uplift in headcount, following the opening of a new design centre in Cambridge coupled with a re-energised recruitment strategy. To meet the growing demand, we have strengthened our leadership team not just in technical areas, but also in operations, engineering, commercial and business development.

We have an exciting technology roadmap, developing semiconductor and passive technologies in the millimetre-wave spectrum for both the ground station, payload and platform systems and components. These are supported by leading edge global semiconductor foundry technologies. The developments relating to these are progressing well and we still expect to deliver against critical timelines.

We continue our aim to deliver increased output from our existing operational facilities and production resources. To meet the strong demand, we successfully introduced two new production lines during the period to give further flexibility and enable further conversion of new business. As we move to larger premises at our headquarters in Sedgefield, County Durham, later this year we expect to see further gains to capacity and efficiency.

Financial Performance Summary

The Board are pleased with the trading results in H1. Coupled with this, strong order intake resulted in the improved revenue and profit outlook in H2 which we communicated in December and January.

Group revenue for the first half of FY2025 increased by over 200% on the prior year with sales of £25.6m (H1 2024: £8.5m).

We have invested further in the business during the period to support the growth, leading to our overhead cost base increasing by 62%. Despite this, the revenue growth from increased trading has delivered an operating profit of £6.8m (H1 2024: operating loss of £0.4m) and adjusted earnings before interest, taxation, depreciation and amortisation ("adjusted EBITDA") of £8.7m (H1 2024: £0.2m).

At 30 November 2024, the Group recorded cash in the bank of £7.2m (31 May 2024: £7.2m), net cash of £5.1m when excluding the right of use property leases (31 May 2024: £5.2m) and net cash including right of use property leases of £4.3m (31 May 2024: £4.2m).

Our Markets

The Low Earth Orbit ("LEO") space market remains a driving force for the business with the market still offering further significant growth potential.

Our strategic partnership with the market leader, SpaceX, continues to strengthen and grow. The success of the relationship has enabled us to deliver at high volume and high quality, working closely with our business and supply chain partners. This achievement has enabled both parties to consider further collaboration following the remarkable success of the Starlink constellation.

We still see LEO space payload as an exciting area for us and we have factored that into our technology road map. As a lead-in project to payload, we have a prestigious programme underway with the European Space Agency ("ESA") which is expected to complete over the next year with material revenues still to be recognised in FY2026.

We were delighted to see our customers, Almagest Space Corporation and XDLINX Space Labs, take our first mmWave product into space on their recently developed satellite using one of our Morpheus X2 E-band transceivers.

The defence pipeline contains several interesting opportunities particularly within airborne radar systems. Our active programmes, with QinetiQ will substantively complete in FY2025, and with BAE Maritime Systems within FY2026. The UK government's Strategic Defence Review pushed back the planned timing of a number of prospective opportunities but has not impacted financial forecasts.

We are pleased to see the UK Government secure the future of the semiconductor foundry at Newton Aycliffe, County Durham, safeguarding critical semiconductor components for the UK defence market and providing longevity of supply. This creates an opportunity for us to align ourselves with the Defence Industrial Strategy where we can utilise our advanced semiconductor packaging and test capability which we see as essential for sovereign capability and competitiveness.

Outlook

The Group has continued the momentum from H1 with a strong start to trading in H2. Our order book is healthy and underpins the recent upgrades, whilst the opportunity pipeline continues to build serving us well as we move towards the next financial year.

The overall macro factors for the low earth orbit ("LEO") satellite market are robust, driven by the emergence of reusable launch vehicles and advanced manufacturing, which significantly reduces the cost of launch and enables more companies to participate in space activities. Commercial engagements, not only with SpaceX, have demonstrated to us the relevance of our technology to the wider satellite market serving a multitude of missions. This enables us to bring forwards leading-edge high-performance technology that we anticipate could be widely adopted.

The industry growth rates for LEO satellite market are projected to grow at a CAGR of over 9% by 2031 with the overall market size growing to $310bn USD by 2031 (Exactitude Consultancy) whilst the defence market for electronic warfare is expected to grow to 2031 by 7% to $35bn USD (Insight Partners).

I am grateful for the hard work and dedication of the entire Filtronic team and our impressive supply chain partners in their efforts to achieve considerable production volume ramps at the quality that premium markets expect. I would like to take this opportunity to publicly thank them all for their innovation, commitment and success.

Jonathan Neale

Chairman, 3 February 2025

Condensed Consolidated Interim Income Statement

For the period ended 30 November 2024

6 months6 monthsYear
EndedEndedEnded
30 November30 November31 May
202420232024
(Unaudited)(Unaudited)(Audited)
Continuing operationsNote£000£000£000
Revenue525,5958,48025,432
==================
Adjusted EBITDA¹8,7122064,889
Depreciation of property, plant and equipment and right of use assets(607)(451)(945)
Amortisation of intangible assets(258)(124)(287)
Amortisation of contract assets10(901)--
Share-based payments(185)-(47)
------------------------------
Operating profit/(loss)66,761(369)3,610
Finance costs7(127)(166)(332)
Finance income81011883
------------------------------
Profit/(loss) before taxation6,735(517)3,361
Taxation(7)(5)(220)
------------------------------
Profit/(loss) for the period6,728(522)3,141
==================
Basic and diluted earnings/(loss) per share (pence)
Basic earnings/(loss) per share93.08p(0.24p)1.45p
Diluted earnings/(loss) per share93.04p(0.24p)1.41p
==================

1 Adjusted EBITDA is defined as profit before interest, taxation, depreciation, amortization, share-based payments and exceptional items which is a non-GAAP metric used by management and is not an IFRS disclosure.

Condensed Consolidated Interim Statement of Comprehensive Income

For the period ended 30 November 2024

6 months6 monthsYear
EndedEndedEnded
30 November30 November31 May
202420232024
(Unaudited)(Unaudited)(Audited)
£000£000£000
Profit/(loss) for the period6,728(522)3,141
------------------------------

Items that are or may be subsequently reclassified to profit and loss:

6 months6 monthsYear
EndedEndedEnded
30 November30 November31 May
Currency translation arising on consolidation(15)(39)(52)
------------------------------
Total comprehensive income/(expense) for the period6,713(561)3,089
==================

The total comprehensive income/(expense) for the period is attributable to the equity shareholders of the parent company Filtronic plc.

Condensed Consolidated Interim Statement of Financial Position

At 30 November 2024

(restated)

Note30 November30 November31 May
202420232024
(Unaudited)(Unaudited)(Audited*)
£000£000£000
Non-current assets
Goodwill and other intangible assets2,6041,9772,271
Right of use assets3,7743,5663,756
Property, plant and equipment2,0617641,153
Contract assets101,302-1,302
Deferred tax1,0461,2521,047
------------------------------
10,7877,5599,529
------------------------------
Current assets
Inventories4,2022,5693,273
Trade and other receivables15,0704,5456,550
Contract assets10401-1,303
Cash and cash equivalents7,2044,0577,215
------------------------------
26,87711,17118,341
------------------------------
------------------------------
Total assets37,66418,73027,870
------------------------------
Current liabilities
Trade and other payables8,2242,7595,406
Provisions493363493
Deferred Income111,4261,2351,403
Lease liabilities731746895
------------------------------
10,8745,1038,197
------------------------------
Long term liabilities
Deferred income11116537132
Lease liabilities2,2142,0922,121
------------------------------
2,3302,6292,253
------------------------------
------------------------------
Total liabilities13,2047,73210,450
------------------------------
------------------------------
Net assets24,46010,99817,420
==================
Equity
Share capital1210,80010,79610,798
Share premium1311,35211,08711,213
Share warrant reserve102,605-2,605
Translation reserve(537)(509)(522)
Retained earnings240(10,376)(6,674)
------------------------------
Total equity24,46010,99817,420
==================

The total equity is attributable to the equity shareholders of the parent company Filtronic plc.

Company number 2891064

* Certain prior period figures are restated, please refer to note 15 for further information.

Condensed Consolidated Interim Statement of Changes in Equity

For the period ended 30 November 2024

Share capitalShare premiumShare warrant reserveTranslation reserveRetained earningsTotal equity
£000£000£000£000£000£000
Balance at 30 November 202310,79611,087-(509)(10,376)10,998
Profit for the period----3,6633,663
New shares issued (net of issue costs)2126---128
Share warrants--2,6052,605
Currency translation movement arising on consolidation---(13)-(13)
Share-based payments----3939
------------------------------------------------------------
Balance at 31 May 2024 (restated*)10,79811,2132,605(522)(6,674)17,420
Profit for the period----6,7286,728
New shares issued (net of issue costs)2139---141
Currency translation movement arising on consolidation---(15)-(15)
Share-based payments----186186
------------------------------------------------------------
Balance at 30 November 202410,80011,3522,605(537)24024,460
====================================

* Certain prior period figures are restated, please refer to note 15 for further information.

Condensed Consolidated Interim Cash Flow Statement

For the period ended 30 November 2024

6 months6 monthsYear
EndedEndedEnded
30 November30 November31 May
202420232024
(Unaudited)(Unaudited)(Audited)
£000£000£000
Cash flows from operating activities
Profit/(loss) for the period6,728(522)3,141
Taxation75220
Finance income(101)(18)(83)
Finance costs127166332
------------------------------
Operating profit/(loss)6,761(369)3,610
Tax paid(7)(5)(16)
Share-based payments186847
Depreciation607451945
Amortisation of contract assets901--
Amortisation of intangible assets258124287
Movement in inventories(926)186(531)
Movement in trade and other receivables(8,534)766(1,235)
Movement in trade and other payables2,820(906)1,749
Movement in provisions-(1)129
Change in deferred income81,5791,342
------------------------------
Net cash generated from operating activities2,0741,8336,327
------------------------------
Cash flows from investing activities
Capitalisation of development costs(486)(326)(677)
Acquisition of intangible assets(103)-(107)
Acquisition of plant and equipment(1,535)(162)(666)
Acquisition of right of use assets-(34)(120)
Interest received1011483
------------------------------
Net cash used in investing activities(2,023)(508)(1,487)
------------------------------
Cash flows from financing activities
Interest paid(127)(166)(332)
Proceeds from financing agreements--750
Exercise of employee share options14110138
Repayment of principal element of lease liabilities(437)(411)(784)
Receipt of interest-bearing borrowings364684-
------------------------------
Net cash generated (used in)/from financing activities(59)117(228)
------------------------------
Movement in cash and cash equivalents(8)1,4424,612
Currency exchange movements(3)5(7)
Opening cash and cash equivalents7,2152,6102,610
------------------------------
Closing cash and cash equivalents7,2044,0577,215
==================

Notes to the Condensed Financial Statements

1 Company information

Filtronic plc is a company registered and domiciled in the United Kingdom and is listed on the AIM market of the London Stock Exchange. The Company's registered number is 2891064. The address of the Company's registered office is Filtronic plc, Plexus 1, NETPark, Thomas Wright Way, Sedgefield, County Durham, TS21 3FD.

Copies of the Company's Annual Report and interim financial report are available from the Company's registered office or the Company's website at www.filtronic.com.

2 Basis of preparation

Whilst the financial information included in this preliminary statement has been prepared on the basis of the requirements of IFRSs in issue, this statement does not itself contain sufficient information to comply with IFRS.

These financial results for the six months ended 30 November 2024 do not comprise statutory accounts within the meaning of Section 434 of the Companies Act 2006. The interim report should be read in conjunction with the Annual Report 2024, which includes annual financial statements for the year ended 31 May 2024. Those accounts have been reported on by the Company's auditor and delivered to the registrar of companies. The report of the auditor was (i) unqualified (ii) did not include a reference to any matters to which the auditor drew attention by way of emphasis without qualifying their report, and (iii) did not contain a statement under section 498 (2) or (3) of the Companies Act 2006.

The condensed consolidated financial statements for the six months ended 30 November 2024 consolidate the financial statements of the Company and all of its subsidiaries (together referred to as the "Group"). Transactions between Group companies, which are related parties, have been eliminated upon consolidation and therefore do not require disclosure.

The condensed consolidated financial statements for the six months ended 30 November 2024 and comparative period have not been audited. The interim financial report for the six months ended 30 November 2024 was approved by the Board on 3 February 2025.

3 Going Concern

In accordance with corporate governance requirements the directors have undertaken a review of forecasts and the Group's cash requirements to consider whether it is appropriate that the Group continues to adopt the going concern assumption.

The directors have reviewed the projected cash flow and other relevant information, including a 'severe but plausible' scenario and have a reasonable expectation that the Group has adequate resources to continue in operational existence and therefore it remains appropriate to adopt the going concern basis in preparing the interim financial report for the six months ended 30 November 2024.

4 Accounting estimates and judgements

The preparation of the financial statements requires the use of accounting estimates and judgements that affect the application of accounting policies and reported amounts of assets and liabilities, income and expenses. The accounting estimates and judgements are continually evaluated and are based on historical experience and other factors, including expectations of the future that are believed to be reasonable under the circumstances. Actual results may differ from the expected results. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. The accounting estimates and judgements that have a significant effect on the financial statements are considered in the Filtronic plc Annual Report for the year ended 31 May 2024 which can be found on the Filtronic website. Unless stated below there is no material change to those judgements from the Annual Report in the basis of calculation.

There is one change to the accounting estimates and judgements in the period relating to the share warrants issued to SpaceX. This judgement is described in note 10.

5 Segmental Analysis

Operating Segments

Revenue by Destination

The revenue presented is based on the geographic location of customers receiving the product/service from the continuing operations.

6 months6 monthsYear
EndedEndedEnded
30 November30 November31 May
202420232024
£000£000£000
Revenue
United Kingdom1,5591,3962,239
Europe5081,0462,154
Americas23,4463,43317,121
Rest of the world822,6053,918
------------------------------
25,5958,48025,432
==================

Revenue from sales

The revenue presented is based on the Group deriving revenue from product sales and those received from Non-Recurring Engineering ("NRE") at a point in time when the performance obligation is satisfied.

6 months6 monthsYear
EndedEndedEnded
30 November30 November31 May
202420232024
£000£000£000
Revenue
Sales of product25,5658,03124,135
NRE - point in time9314491,297
Amortisation of contract assets(901)--
------------------------------
25,5958,48025,432
==================
6 Operating profit/(loss)
6 months6 monthsYear
EndedEndedEnded
30 November30 November31 May
202420232024
£000£000£000
Revenue25,5958,48025,432
------------------------------
Material cost of goods sold9,7383,2459,357
Wages and salaries4,1873,1716,092
Social security costs469316650
Pension costs269182372
Bonus540-810
Temporary employees418-208
Share-based payments186847
------------------------------
Employee costs6,0693,6778,179
------------------------------
Amortisation of intangible assets258124287
Depreciation of property, plant and equipment and right of use assets607451945
------------------------------
Depreciation and amortisation8655751,232
------------------------------
Other operating income(34)(153)(326)
Other expenses21961,5053,380
------------------------------
Total operating costs9,0965,60412,465
==================
Operating profit/(loss)6,761(369)3,610
==================

Development costs of £486,000 were capitalised in HY2025 (HY2024: £295,000).

Other operating income relates to grants received for plant and machinery and R&D innovation whilst R&D tax credits claimed under the RDEC scheme are also recognised in operating profit.

7 Finance costs

6 months6 monthsYear
EndedEndedEnded
30 November30 November31 May
202420232024
£000£000£000
Interest expense for lease arrangements127114236
Minimum service costs and interest charges on invoice discounting facilities-5296
------------------------------
127166332
==================
8 Finance income
6 months6 monthsYear
EndedEndedEnded
30 November30 November31 May
202420232024
£000£000£000
Revaluation of foreign currency denominated intercompany balance941
Interest receipt on treasury deposits921482
------------------------------
1011883
==================
9 Basic and diluted earnings/(loss) per share
6 months6 monthsYear
EndedEndedEnded
30 November30 November31 May
202420232024
£000£000£000
Profit/(loss) for the period6,728(522)3,141
==================
'000'000'000
Basic weighted average number of shares218,771215,172216,340
Dilution effect of share options2,6632,7816,555
--------------------------------
Diluted weighted average number of shares221,434217,953222,895
====================
Basic earnings/(loss) per share (pence)3.08p(0.24p)1.45p
Diluted earnings/(loss) per share (pence)3.04p(0.24p)1.41p
==================

10 SpaceX share warrants

On 24 April 2024, the Group entered into a share warrant arrangement with SpaceX in conjunction with a commercial agreement and strategic partnership. This related to the supply of E-band Solid State Power Amplifiers ("SSPAs") and new technology being developed for SpaceX for use in their Starlink constellation. Full details of the warrants can be found in the 2024 Annual Report and Accounts in note 31.

The warrant agreement grants SpaceX the right to acquire up to 21,712,109 shares of the Company (equivalent to 10% of the Company's total share capital at the inception of the warrant agreement). The exercise price of vested warrants is 33.0p per share, based on the closing mid-market price at 23 April 2024, which is the date prior to signing the warrant agreement. The directors have assessed the warrants and have made a judgement that the warrants should be treated as equity instruments as defined by IAS32. This is because the warrants have a fixed consideration at 33.0p per share for a fixed number of units to exercise.

The warrants have been recognised in the financial statements based on the value at the date of signing of the agreement. An initial entry has been made in contract assets measured at fair value, but not subsequently remeasured with the corresponding entry to equity. As the warrants represent non-cash consideration payable to a customer under IFRS 15. The contract asset, which effectively represents a deferred volume rebate, is amortised to revenue based on when the units are supplied to SpaceX. In this period under review, this represented a £901,000 charge to revenue.

The initial fair value of the warrants at inception was £2,605,453, based on a fair value per warrant of £0.11 and the total number of warrants expected to vest over the 5-year vesting period. The directors have judged all of the warrants will vest, otherwise SpaceX and Filtronic would not have entered into the agreement.

11 Deferred income

6 months6 monthsYear
EndedEndedEnded
30 November30 November31 May
202420232024
£000£000£000
Contract liabilities1,4841,1981,369
Capital grant293734
---------------------------------
Total current deferred income1,5131,2351,403
---------------------------------
Contract liabilities-392-
Capital grant116145132
--------------------------------
Total non-current deferred income116537132
---------------------------------
Total deferred income1,6291,7721,535
=====================

Contract liabilities are invoices raised in advance of NRE work completed for customers that will be recognised as income once the performance obligation of the contract has been met. The majority of NRE contracts are invoiced with a proportion of the contract value upfront which is recognised as revenue, over time, across the life of contract at each milestone based on the percentage of the overall contract value achieved at that performance obligation.

12 Share Capital

Deferred shares of 10p eachOrdinary shares of 0.1p each
Number '000Number '000£000
At 30 November 2023106,877215,32110,796
Exercise of employee share options-1,8002
--------------------------- -----------
At 31 May 2024106,877217,12110,798
Exercise of employee share options-1,8612
-------------------------------------
At 30 November 2024106,877218,98210,800
========================

All shares are allotted, called up and fully paid. Holders of the ordinary shares and entitled to retrieve dividends when declared and are entitled to one vote per share at meetings of the company.

Holders of the ordinary shares are entitled to receive dividends when declared and are entitled to one vote per share at meetings of the Company.

13 Share Premium

£000

At 30 November 202311,087
Exercise of employee share options126
-----------
At 31 May 202411,213
Exercise of employee share options139
-----------
At 30 November 202411,352
=======
14 Analysis of net cash
1 June 2024Cash FlowOther movements30 Nov 2024
£000£000£000£000
Cash and cash equivalents7,215(8)(3)7,204
Lease liability - plant and equipment(1,990)296(363)(2,057)
------------------------------------
Net cash when including all debt except property leases5,225288(366)5,147
Lease liability - property lease(1,027)139-(888)
------------------------------------
Net cash4,198427(366)4,259
========================

Cash at bank earns interest at floating rates based on daily bank deposit rates.

The Group entered into a new financing arrangement in November 2024 with Santander UK plc. This included the operational banking facilities and successful attainment of a committed £5.0m Revolving Credit Facility ("RCF") for three years from November 2024. Consequently, the invoice discounting facilities with Barclays Bank and Wells Fargo have been closed.

There were no drawings on the RCF facility at 30 November 2024 (31 May 2024: undrawn).

15 Restatement of financial statements

Restatements have been made to some of the financial statements for the period ended 31 May 2024. This impacted the Consolidated Statement of Financial Position and Statement of Changes In Equity but there have been no amendments to the income statement or cash flow statement.

The share warrants have been restated in line with the IAS 32 accounting standard which requires the fair value of share warrants to be accounted for as a contract asset with a corresponding entry to equity or financial liability. The director's judged this to be accounted for as equity. IAS 32 requires for this to be accounted at the time the warrant agreement was signed. Consequently, the contract asset in FY2024 increased by £2.6m, prior to amortisation, and equity in the share warrant reserve increased by £2.6m.

31 May31 May
20242024
(Audited)Correction(Audited*)
£000£000£000
Non-current assets
Contract assets-1,3021,302
------------------------------
8,2271,3029,529
------------------------------
Current assets
Contract assets-1,3031,303
------------------------------
17,0381,30318,341
------------------------------
------------------------------
Total assets25,2652,60527,870
------------------------------
------------------------------
Net assets14,8152,60517,420
==================
Equity
Share warrant reserve-2,6052,605
------------------------------
Total equity14,8152,60517,420
==================

* Certain prior period figures are restated, please refer to note 15 for further information.

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note